After Remission, What Next? Rethinking Rituximab Strategy in Idiopathic Nephrotic Syndrome
Zohreh Gholizadeh Ghozloujeh, MD, is a research postdoctoral fellow in the Division of Nephrology at Loma Linda University School of Medicine. Her work focuses on rare kidney [...]